Allergan Plc

Allergan Plc

Allergan Plc

Overview
Date Founded

1984

Headquarters

Clonshaugh Business & Tech. Park,Coolock,Dublin D17 E400

Type of Company

Public

Employees (Worldwide)

16.9K

Industries

Pharmaceuticals

Company Description

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

Contact Data
Trying to get in touch with decision makers at Allergan Plc? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman, President & Chief Executive Officer

Executive Vice President & Chief Financial Officer

Senior Vice President & Chief Financial Officer

Executive Vice President & Chief Financial Officer

Executive Vice President & Chief Commercial Officer

Chief Accounting Officer

Chief Human Resources Officer & Senior Vice President

Chief Communications Officer

Chief R&D Officer

Executive Vice President & Chief Legal Officer & Corporate Secretary

Board of Directors

Co-Founder at Graybug Vision, Inc.

Director-FM Kirby Neurobiology Center at Boston Children’s Hospital

President at Abbott Laboratories (Puerto Rico), Inc.

Former Vice President of Corporate Controller at Dell, Inc.

Former Chairman of the Board, President & Chief Executive Officer at Celgene Corp.

Associate Chief & Clinical Director, Infectious Disease Division at The Massachusetts General Hospital

Advisory Partner at NewSpring Capital

Venture Partner at Flying Fish Management LLC

Chief Financial Officer at Dun & Bradstreet, Inc.

Head-Sales at Xerox Corporation

Paths to Allergan Plc
Potential Connections via
Relationship Science
You
Allergan Plc
Owners & Shareholders
Details Hidden

GIC-IM's investment teams manage a broad-based portfolio of asset classes. A focus on intrinsic value and price discipline guides them as they structure and pursue investment opportunities across asset classes and the capital structure. The team decides how to implement the asset policy mix in terms of the various investment strategies, proportion of funds to be actively/passively managed, allocation of risk capital and the selection of managers. The firm's portfolio managers then construct portfolios based on considerations of currency management, country selection, industry/sector allocation, yield curve management and security selection. GIC-IM's Board of Directors sets the policy asset mix and decides on a policy portfolio which specifies the allocation of funds to eligible asset classes. Investment decisions are based on analysis of fundamentals in line with long-term sustainable performance.

Details Hidden

Longview Partners is a specialist asset management company focused entirely on the management of Global Equity portfolios. They are an active manager which utilizes a bottom-up, evidence-based process to seek investment opportunities based on fundamental research. The primary focus of the firm's investment process is to invest in high quality companies with strong business fundamentals and attractive cash-based valuations. Longview Partners uses its own in-house models to conduct this analysis. Longview Partners focus on three criteria for security selection: Quality, Business Fundamentals and Valuation. They also have a strict sell-discipline which is consistently adhered to. It is these bottom-up buy and sell decisions that drive portfolio construction.

Details Hidden

Founded in 2003 Credit Suisse USA LLC is a broker/dealer headquartered in New York City with offices worldwide. The firm is a subsidiary of Credit Suisse Group AG (NYSE: CS).The Credit Suisse equity research equity group engages in a broad range of activities for investors including sales, trading, financing, prime brokerage and market-making in US and international equity and equity related securities, options, futures, risk management and hedging products. Their activities cover both exchange-traded and over-the-counter traded securities, including American depository receipts, restricted stocks, equity repurchases, block trade executions, program trading executions, equity derivatives and convertible securities.Their fixed-income franchise operates as a single, unified platform that handles all fixed-income cash and derivative products. Products and services range from securitization and liability management transactions to sales and trading and superior research.

Recent Transactions
Details Hidden

AbbVie, Inc. purchases Allergan Plc

Details Hidden

Allergan Plc purchases Envy Medical, Inc. from HCP & Co.

Details Hidden

Allergan Plc purchases Bonti, Inc. from Colt Ventures Ltd., City Hill Ventures LLC, Highlight Capital, RusBio Ventures LLC

Transaction Advisors
Legal Advisor

Advised onAllergan Plc purchases Allergan, Inc.

Legal Advisor

Advised onAbbVie, Inc. purchases Allergan Plc

Legal Advisor

Advised onAllergan Plc purchases Zeltiq Aesthetics, Inc.

Legal Advisor

Advised onAllergan Plc purchases Zeltiq Aesthetics, Inc.

Legal Advisor

Advised onAllergan Plc purchases Zeltiq Aesthetics, Inc.

Legal Advisor

Advised onAllergan Plc purchases Zeltiq Aesthetics, Inc.

Advisors & Consultants
Advisor

Chief Financial Officer at Actavis Elizabeth LLC

Legal Advisor

US Chair, Life Sciences Patent Litigation Practice at DLA Piper

Consultant

Former Senior Vice President, Finance & Treasurer at PepsiCo, Inc.

Clients

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

McKesson is dedicated to delivering the vital medicines, medical supplies and information technologies that enable the health care industry to provide patients better, safer care. McKesson is made up of many businesses, all serving the health care industry. Our businesses fall into one of two primary categories: Distribution solutions. We are the largest pharmaceutical distributor in North America, distributing one-third of the medicines used every day. As one of the leading pharmaceutical companies, we supply more than 40,000 U.S. pharmacy locations, from Wal-Mart to the Department of Veterans Affairs to community pharmacies and hospitals. McKesson is also one of the leading medical supply companies and distributes medical-surgical supplies and homecare supplies. Healthcare Technology solutions. We develop and install healthcare information technology systems that eliminate the need for paper prescriptions and paper medical records. Our software and hardware are used in more than 70% of the nation's hospitals with more than 200 beds. Our hospital information system solutions include electronic health record system (EHR) and clinical decision support system such as Interqual. McKesson's Healthcare IT division also serves diverse areas within the health industry by offering solutions such as pharmacy automation and medical claims management software. McKesson publicly traded on NYSE under MCK Businesses Serving our customers—pharmacies, medical and pharmaceutical manufacturers, hospitals, and insurers—as the health care industry evolves is our primary goal. We have business lines to automate processes from medical supplies packaging to claims management, and revenue cycle management to medical imaging. McKesson's long history in pharmaceutical industry History McKesson has a long history in health care. We’ve been a trusted provider of medical supplies and goods for more than 175 years.

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Key Stats and Financials As of 2018
Market Capitalization
$62.5B
Total Enterprise Value
$67B
Earnings Per Share
$-15.26
Revenue
$15.8B
Net Profit
$-5.1B
Total Debt
$23.8B
Total Equity
$65.1B
Debt TEV
0.36x
Enterprise Value Sales
4.24x
TEVNet Income
-13.14x
EBITDA
$7.11B
EBITDAMargin
45.04%
Enterprise Value EBITDAOperating
9.42x
Three Year Compounded Annual Growth Rate Of Revenue
1.56%
Five Year Compounded Annual Growth Rate Of Revenue
12.72%
Investors
Details Hidden

Chief Executive Officer at Innocrin Pharmaceuticals, Inc.

Details Hidden

Co-Founder at Longitude Capital Management Co. LLC

Details Hidden

Managing Partner at Vivo Capital LLC

Suppliers
Antares Pharma, Inc. Medical Products & Equipment | EWING, NJ

Antares Pharma is a revenue-generating product focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA approved products. Our products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. We focus on self-injection pharmaceutical products and technologies and topical gel -based products. Our subcutaneous injection technology platforms include Vibex™ disposable pressure-assisted auto injectors, Vision® reusable needle-free injectors, and disposable multi-use pen injectors.

Ironwood Pharmaceuticals, Inc. Pharmaceuticals | Cambridge, MA

At Ironwood, we seek to transform knowledge into medicines that make a difference for patients. Patients shape our business. They influence our drugmaking process, helping us to understand and address their unmet medical needs, whether we’re creating a new medicine or tackling the equally challenging task of delivering that medicine to people around the world. Our employees shape our success. Since our founding in 1998, each of our employees has held shares in the company. Being owners of Ironwood means we are all careful stewards of our resources: we take a data-driven approach in which we celebrate definitive answers – whether those answers support holding steady or changing course – and we challenge every program to earn its way forward. Our discovery and development processes have generated a product that’s approved in the United States and in the European Union, as well as a robust pipeline. As we continue to do drugmaking well, we hope to inspire the support of our shareholders and earn the right to do it again – building an enduring pharmaceutical company that understands and addresses people’s needs.

The Chemical Works of Gedeon Richter Plc Pharmaceuticals | Budapest, BU

The Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale and Retail, and Others. The Pharmaceutical segment engages in research and development, manufacturing, sales and marketing of pharmaceutical products. The Wholesale and Retail segment represents the distribution chain in the market which facilitate the product reaching the final buyers. The Other segment relates to the business of the members of the group that do not belong to any of the segments. The company was founded by Gedeon Richter in 1901 and is headquartered in Budapest, Hungary.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Allergan Plc. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Allergan Plc's profile does not indicate a business or promotional relationship of any kind between RelSci and Allergan Plc.